Synergistic lifespan extension can be achieved not just by targeting the same HAs but the same biological processes, e.g., elevated expression of oncosupressors p53 and Arf extended mice median lifespan 16%, while p53 alone only decreased tumor incidence, and Arf had a very weak effect on lifespan [93]. The gene discussed is TP53; the disease is neoplasm.